Broad Institute, Inc. - 21 Jun 2021 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
10%+ Owner
Signature
/s/ Dan Shore, Chief Financial Officer
Issuer symbol
VERV
Transactions as of
21 Jun 2021
Net transactions value
$0
Form type
4
Filing time
23 Jun 2021, 18:13:03 UTC
Previous filing
16 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERV Common Stock Other $0 +387,830 +92% $0.000000 809,784 21 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Broad Institute, Inc. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 These shares were issued upon the closing of the Issuer's initial public offering in satisfaction of contractual obligations, based on the initial public offering price of $19.00 per share, without payment of any additional consideration by The Broad Institute, Inc. at the time of issuance.